A phase II/III, observer-blind, randomised, active controlled study to compare the safety and immunogenicity of a meningococcal A conjugate vaccine (PsA-TT) with meningococcal ACWY polysaccharide vaccine administered in healthy subjects 2 to 29 years of age

Trial Profile

A phase II/III, observer-blind, randomised, active controlled study to compare the safety and immunogenicity of a meningococcal A conjugate vaccine (PsA-TT) with meningococcal ACWY polysaccharide vaccine administered in healthy subjects 2 to 29 years of age

Completed
Phase of Trial: Phase II/III

Latest Information Update: 14 Sep 2016

At a glance

  • Drugs Aluminium phosphate; Meningococcal vaccine group A conjugate; Meningococcal vaccine groups A C Y W-135 polysaccharide
  • Indications Bacterial meningitis; Meningococcal infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Serum Institute of India
  • Most Recent Events

    • 15 Nov 2015 Results published in the Clinical Infectious Diseases
    • 16 Jun 2011 Primary endpoint 'Seroconversion-rate' has been met.
    • 16 Jun 2011 Results published in the New England Journal of Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top